- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 159 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- January 2024
- 285 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- July 2024
- 74 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4278EUR$4,500USD£3,594GBP
The Herpes Marker market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of the herpes simplex virus (HSV) and other related viruses. Herpes Marker tests are used to diagnose and monitor the progression of the virus, as well as to determine the effectiveness of treatments. Tests are available in both laboratory and point-of-care settings, and can be used to detect HSV-1, HSV-2, and other related viruses.
Herpes Marker tests are used in a variety of clinical settings, including primary care, obstetrics and gynecology, and dermatology. They are also used in research settings to study the epidemiology of the virus.
Some companies in the Herpes Marker market include Abbott, Bio-Rad, Roche, Siemens, and Thermo Fisher Scientific. Show Less Read more